SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-028984
Filing Date
2019-08-06
Accepted
2019-08-06 07:16:48
Documents
69
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20190630.htm   iXBRL 10-Q 3078598
2 EX-10.1 sage-ex101_50.htm EX-10.1 64645
3 EX-31.1 sage-ex311_8.htm EX-31.1 9596
4 EX-31.2 sage-ex312_6.htm EX-31.2 9532
5 EX-32.1 sage-ex321_7.htm EX-32.1 8898
6 GRAPHIC gzjlqiticd3k000001.jpg GRAPHIC 36955
7 GRAPHIC gzjlqiticd3k000006.jpg GRAPHIC 88773
8 GRAPHIC gxsf1ubx5ntp000001.jpg GRAPHIC 35183
  Complete submission text file 0001564590-19-028984.txt   10138040

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA sage-20190630.xsd EX-101.SCH 55088
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20190630_cal.xml EX-101.CAL 51533
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20190630_def.xml EX-101.DEF 207773
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20190630_lab.xml EX-101.LAB 413823
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20190630_pre.xml EX-101.PRE 342292
14 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20190630_htm.xml XML 1975701
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 191000419
SIC: 2834 Pharmaceutical Preparations